For the quarter ending 2025-12-31, MLAB had $8,553K increase in cash & cash equivalents over the period. $18,022K in free cash flow.
| Cash Flow | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Net income | 3,630 | 2,476 | 4,742 |
| Depreciation of property, plant and equipment | 1,270 | 1,315 | 1,404 |
| Amortization of intangible assets | 4,445 | 4,534 | 4,553 |
| Stock-based compensation expense | 3,382 | 3,812 | 3,881 |
| Gain on extinguishment of convertible notes | 0 | 0 | 0 |
| Amortization of step-up in inventory basis | 0 | 0 | 0 |
| Foreign currency adjustments | -281 | 95 | 5,986 |
| Other | -1,262 | -1,628 | -1,250 |
| Accounts receivable, net | 819 | 1,696 | -3,436 |
| Inventories | -596 | 766 | 3,290 |
| Prepaid expenses and other assets | 715 | -1,613 | 2,436 |
| Accounts payable | 124 | -1,209 | 212 |
| Accrued liabilities and taxes payable | 5,054 | -2,577 | -5,928 |
| Unearned revenues | 244 | -813 | 55 |
| Net cash provided by operating activities | 18,754 | 8,222 | 1,893 |
| Purchases of property, plant and equipment | 732 | 1,092 | 1,009 |
| Net cash (used in) investing activities | -732 | -1,092 | -1,009 |
| Proceeds from debt borrowings | 0 | 97,000 | 10,500 |
| Repurchase and settlement of convertible note debt | 0 | 97,500 | 0 |
| Other debt principal repayments | 8,687 | 5,937 | 7,438 |
| Gke acquisition-related holdback payment-Gke Acquisition | 0 | 0 | 9,555 |
| Dividends paid | 884 | 882 | 873 |
| Other financing, net | -214 | -564 | -1,061 |
| Net cash (used in) financing activities | -9,785 | -7,883 | -8,427 |
| Effect of exchange rate changes on cash and cash equivalents | 316 | -104 | 1,501 |
| Net increase in cash and cash equivalents | 8,553 | -857 | -6,042 |
| Cash and cash equivalents at beginning of period | 20,422 | 27,321 | - |
| Cash and cash equivalents at end of period | 28,975 | 20,422 | - |
MESA LABORATORIES INC CO (MLAB)
MESA LABORATORIES INC CO (MLAB)